Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:BAKKA - FO0000000179 - Common Stock

480 NOK
+4.6 (+0.97%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

4

Overall BAKKA gets a fundamental rating of 4 out of 10. We evaluated BAKKA against 63 industry peers in the Food Products industry. BAKKA has an average financial health and profitability rating. BAKKA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BAKKA was profitable.
In the past year BAKKA had a positive cash flow from operations.
In the past 5 years BAKKA has always been profitable.
Each year in the past 5 years BAKKA had a positive operating cash flow.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

BAKKA has a Return On Assets of 2.29%. This is comparable to the rest of the industry: BAKKA outperforms 44.44% of its industry peers.
BAKKA's Return On Equity of 4.00% is in line compared to the rest of the industry. BAKKA outperforms 41.27% of its industry peers.
BAKKA has a worse Return On Invested Capital (3.33%) than 60.32% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BAKKA is in line with the industry average of 6.78%.
Industry RankSector Rank
ROA 2.29%
ROE 4%
ROIC 3.33%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of BAKKA (6.45%) is better than 69.84% of its industry peers.
BAKKA's Profit Margin has declined in the last couple of years.
BAKKA has a better Operating Margin (11.29%) than 69.84% of its industry peers.
BAKKA's Operating Margin has declined in the last couple of years.
The Gross Margin of BAKKA (70.51%) is better than 96.83% of its industry peers.
In the last couple of years the Gross Margin of BAKKA has remained more or less at the same level.
Industry RankSector Rank
OM 11.29%
PM (TTM) 6.45%
GM 70.51%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAKKA is destroying value.
The number of shares outstanding for BAKKA remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BAKKA has more shares outstanding
The debt/assets ratio for BAKKA has been reduced compared to a year ago.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.61 indicates that BAKKA is not a great score, but indicates only limited risk for bankruptcy at the moment.
BAKKA's Altman-Z score of 2.61 is fine compared to the rest of the industry. BAKKA outperforms 71.43% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that BAKKA is not too dependend on debt financing.
The Debt to Equity ratio of BAKKA (0.49) is better than 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 2.61
ROIC/WACC0.4
WACC8.22%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BAKKA has a Current Ratio of 5.92. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.92, BAKKA belongs to the top of the industry, outperforming 98.41% of the companies in the same industry.
BAKKA has a Quick Ratio of 1.50. This is a normal value and indicates that BAKKA is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.50, BAKKA belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.92
Quick Ratio 1.5
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

BAKKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.91%.
Measured over the past years, BAKKA shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.36% on average per year.
Looking at the last year, BAKKA shows a very negative growth in Revenue. The Revenue has decreased by -14.37% in the last year.
BAKKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.21% yearly.
EPS 1Y (TTM)-50.91%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-100%
Revenue 1Y (TTM)-14.37%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-2.9%

3.2 Future

Based on estimates for the next years, BAKKA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.08% on average per year.
The Revenue is expected to grow by 5.92% on average over the next years.
EPS Next Y-46.82%
EPS Next 2Y6.86%
EPS Next 3Y14.08%
EPS Next 5YN/A
Revenue Next Year-9.04%
Revenue Next 2Y5.69%
Revenue Next 3Y5.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 35.16 indicates a quite expensive valuation of BAKKA.
BAKKA's Price/Earnings ratio is a bit more expensive when compared to the industry. BAKKA is more expensive than 65.08% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.25. BAKKA is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 14.46, which indicates a correct valuation of BAKKA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BAKKA is on the same level as its industry peers.
BAKKA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 35.16
Fwd PE 14.46
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAKKA indicates a slightly more expensive valuation: BAKKA is more expensive than 65.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.22
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

A more expensive valuation may be justified as BAKKA's earnings are expected to grow with 14.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.86%
EPS Next 3Y14.08%

4

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.74%. Purely for dividend investing, there may be better candidates out there.
BAKKA's Dividend Yield is comparable with the industry average which is at 2.42.
BAKKA's Dividend Yield is a higher than the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BAKKA pays out 119.64% of its income as dividend. This is not a sustainable payout ratio.
BAKKA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP119.64%
EPS Next 2Y6.86%
EPS Next 3Y14.08%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (1/12/2026, 7:00:00 PM)

480

+4.6 (+0.97%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-09 2026-02-09/amc
Inst Owners58.12%
Inst Owner ChangeN/A
Ins Owners16.06%
Ins Owner ChangeN/A
Market Cap28.51B
Revenue(TTM)6.48B
Net Income(TTM)418.35M
Analysts75.29
Price Target551.31 (14.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend13.7
Dividend Growth(5Y)3.15%
DP119.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-103.05%
Min EPS beat(2)-106.11%
Max EPS beat(2)-100%
EPS beat(4)0
Avg EPS beat(4)-55.91%
Min EPS beat(4)-106.11%
Max EPS beat(4)-2.8%
EPS beat(8)2
Avg EPS beat(8)-35.96%
EPS beat(12)3
Avg EPS beat(12)-28.7%
EPS beat(16)3
Avg EPS beat(16)-25.81%
Revenue beat(2)0
Avg Revenue beat(2)-19.64%
Min Revenue beat(2)-21.74%
Max Revenue beat(2)-17.55%
Revenue beat(4)0
Avg Revenue beat(4)-17.72%
Min Revenue beat(4)-21.74%
Max Revenue beat(4)-12.67%
Revenue beat(8)1
Avg Revenue beat(8)-12.45%
Revenue beat(12)3
Avg Revenue beat(12)-6.4%
Revenue beat(16)5
Avg Revenue beat(16)-5.43%
PT rev (1m)0%
PT rev (3m)10.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.22%
EPS NY rev (1m)-10.71%
EPS NY rev (3m)-25.05%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)-7.55%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)-5.41%
Valuation
Industry RankSector Rank
PE 35.16
Fwd PE 14.46
P/S 2.79
P/FCF N/A
P/OCF 25.87
P/B 1.73
P/tB 3.04
EV/EBITDA 15.22
EPS(TTM)13.65
EY2.84%
EPS(NY)33.21
Fwd EY6.92%
FCF(TTM)-11.92
FCFYN/A
OCF(TTM)18.55
OCFY3.86%
SpS172.06
BVpS277.37
TBVpS157.74
PEG (NY)N/A
PEG (5Y)N/A
Graham Number291.87
Profitability
Industry RankSector Rank
ROA 2.29%
ROE 4%
ROCE 4.19%
ROIC 3.33%
ROICexc 3.38%
ROICexgc 4.59%
OM 11.29%
PM (TTM) 6.45%
GM 70.51%
FCFM N/A
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexgc growth 3Y13.09%
ROICexgc growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 3.4
Cap/Depr 150.41%
Cap/Sales 17.71%
Interest Coverage 250
Cash Conversion 46.74%
Profit Quality N/A
Current Ratio 5.92
Quick Ratio 1.5
Altman-Z 2.61
F-Score4
WACC8.22%
ROIC/WACC0.4
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.91%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-100%
EPS Next Y-46.82%
EPS Next 2Y6.86%
EPS Next 3Y14.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.37%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-2.9%
Revenue Next Year-9.04%
Revenue Next 2Y5.69%
Revenue Next 3Y5.92%
Revenue Next 5YN/A
EBIT growth 1Y-47.53%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year6.72%
EBIT Next 3Y27.96%
EBIT Next 5YN/A
FCF growth 1Y-298.74%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y-53.9%
OCF growth 3Y27.94%
OCF growth 5Y17.84%

BAKKAFROST P/F / BAKKA.OL FAQ

What is the fundamental rating for BAKKA stock?

ChartMill assigns a fundamental rating of 4 / 10 to BAKKA.OL.


Can you provide the valuation status for BAKKAFROST P/F?

ChartMill assigns a valuation rating of 1 / 10 to BAKKAFROST P/F (BAKKA.OL). This can be considered as Overvalued.


How profitable is BAKKAFROST P/F (BAKKA.OL) stock?

BAKKAFROST P/F (BAKKA.OL) has a profitability rating of 5 / 10.


What is the expected EPS growth for BAKKAFROST P/F (BAKKA.OL) stock?

The Earnings per Share (EPS) of BAKKAFROST P/F (BAKKA.OL) is expected to decline by -46.82% in the next year.


How sustainable is the dividend of BAKKAFROST P/F (BAKKA.OL) stock?

The dividend rating of BAKKAFROST P/F (BAKKA.OL) is 4 / 10 and the dividend payout ratio is 119.64%.